Funded Tech Companies
Memento Medicines
Memento Medicines is a biopharmaceutical growth company, located in Boston. Venture investment and financing came from Avego Healthcare Capital, Forbion Capital Partners and Sanofi Ventures.
Company Overview
Company Name
Memento Medicines
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Company Background Information
Overview
Memento Medicines is a biotech company advancing novel antibody therapies for ophthalmology. Founded in 2026 as the fifth subsidiary of Sera Medicines, a biologics-focused antibody accelerator formed in collaboration with RA Capital, the Company is committed to developing new therapies for patients living with retinal diseases. Memento's lead program, MMT-205, is a potential best-in-class bispecific antibody that activates Tie2 and inhibits VEGF, in development for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/19/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Naveen Daryani
Company Investors
- Avego Healthcare Capital
- Forbion Capital Partners
- Sanofi Ventures
- RA Capital Management
- Samsara BioCapital
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs